LY4065967
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LY4065967, covering 2025-04-03 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain [Phase 2]